Beyond a detailed description of the manufacture of Cryoprecipitated AHF and its contents, this program will review guideline-based indications for use of the product. We will focus primarily on evidence for its use as a fibrinogen supplement and alternative sources of fibrinogen, touching briefly on the variety of conditions for which cryoprecipitate is considered second-line therapy. We will also discuss dosing recommendations so learners can assist clinicians in ordering the appropriate amount in the right clinical circumstances.
Upon completion of the workshop, the participant will be able to:
Blood Systems, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program
In 1977, P.A.C.E.® was established by the American Society of Clinical Laboratory Science (ASCLS) to stimulate and serve as the quality assurance mechanism for continuing education programs offered to clinical laboratory professionals. ASCLS strongly supports continuing education opportunities to increase and enhance professional knowledge and ongoing proficiency. P.A.C.E.® ensures that the continuing education programs offered to clinical laboratory professionals maintain high standards of quality and professional acceptability.
To view the program material, you need a computer with a supported web browser and a dial-up or better internet connection. The supported operating systems and web browsers are:
Copyright © 2018 Blood Systems e-Learning Center. All Rights Reserved
P.A.C.E. is a registered trademark of American Society for Clinical Laboratory Science